92 related articles for article (PubMed ID: 10842997)
1. [Atypical meningioma: morphometric analysis of nuclear pleomorphism].
Pennella A; Ferri C; Lettini T; Serio G; Cimmino A; Caniglia DM; Giangaspero F; Ricco R
Pathologica; 2000 Feb; 92(1):25-31. PubMed ID: 10842997
[TBL] [Abstract][Full Text] [Related]
2. Quantitative morphometrical investigation of basal cell layer in laryngeal premalignant lesions.
Serio G; Giardina C; Valente T; Pennella A; Lettini T; Dalena AM; D'Eredità G; Ricco R; Resta L
J Exp Clin Cancer Res; 2002 Dec; 21(4):495-502. PubMed ID: 12636095
[TBL] [Abstract][Full Text] [Related]
3. Recurring intracranial meningiomas. Morphometrical evaluation of nuclear pleomorphism by S.A.M. (shape analytical morphometry) system.
Serio G; Caniglia A; Ferri C; Caniglia DM; Lettini T; Carlucci M; D'Aprile M; Cimmino A; Serio R; Ricco R
Boll Soc Ital Biol Sper; 1996; 72(5-6):147-53. PubMed ID: 9009052
[TBL] [Abstract][Full Text] [Related]
4. Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors.
Cerdá-Nicolás M; López-Ginés C; Pérez-Bacete M; Barcia-Salorio JL; Llombart-Bosch A
Clin Neuropathol; 2000; 19(6):259-67. PubMed ID: 11128617
[TBL] [Abstract][Full Text] [Related]
5. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
Grunewald JP; Röhl FW; Kirches E; Dietzmann K
Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
[TBL] [Abstract][Full Text] [Related]
6. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas.
Schittenhelm J; Mittelbronn M; Roser F; Tatagiba M; Mawrin C; Bornemann A
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):525-31. PubMed ID: 16972886
[TBL] [Abstract][Full Text] [Related]
7. De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome.
Krayenbühl N; Pravdenkova S; Al-Mefty O
Neurosurgery; 2007 Sep; 61(3):495-503; discussion 503-4. PubMed ID: 17881961
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
9. Cytodiagnosis of meningioma with atypical cytologic features.
Riazmontazer N; Bedayat G
Acta Cytol; 1991; 35(5):501-4. PubMed ID: 1927189
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
11. The accuracy of meningioma grading: a 10-year retrospective audit.
Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
[TBL] [Abstract][Full Text] [Related]
12. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
[TBL] [Abstract][Full Text] [Related]
13. Crush preparations of meningiomas: can grading be accomplished?
Ali S; Nassar A; Siddiqui MT
Diagn Cytopathol; 2008 Nov; 36(11):827-31. PubMed ID: 18831022
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
15. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
16. Lipid signal in evaluation of intracranial meningiomas.
Qi ZG; Li YX; Wang Y; Geng DY; Li KC; Shen TZ; Chen XR
Chin Med J (Engl); 2008 Dec; 121(23):2415-9. PubMed ID: 19102960
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
18. Atypical meningiomas: WHO moved the goalposts?
Smith SJ; Boddu S; Macarthur DC
Br J Neurosurg; 2007 Dec; 21(6):588-92. PubMed ID: 18071986
[TBL] [Abstract][Full Text] [Related]
19. [Atypical and malignant intracranial meningiomas].
Gelabert-González M; Fernández-Villa JM; Iglesias-Pais M
Rev Neurol; 2004 Feb 16-29; 38(4):304-10. PubMed ID: 14997451
[TBL] [Abstract][Full Text] [Related]
20. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
